ArticleOrphanet journal of rare diseases2021

Sebelipase alfa enzyme replacement therapy in Wolman disease: a nationwide cohort with up to ten years of follow-up.

Tanguy Demaret et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.